SLC5A5 and thyroid cancer: Although the strong intracellular staining observed in breast and thyroid cancers proved to be mainly due to nonspecific binding of the antibodies by our group [71], we cannot rule out that altered NIS localization in thyroid cancer cells could contribute to lower its expression at the plasma membrane and to reduce the NIS-mediated iodide uptake.